The ROE (Return on Equity) of Lyell Immunopharma Inc (LYEL) is -89.60%.
ROE (Return on Equity) shows how effectively a company utilizes shareholders equity to produce earnings. It serves as a key indicator of financial return for investors.
| Date | Value |
|---|---|
| 2024-12-31 | -89.60% |
| 2023-12-31 | -35.82% |
| 2022-12-31 | -21.98% |
| 2021-12-31 | -26.91% |
| 2020-12-31 | -28.46% |
| 2019-12-31 | -31.70% |